Reduce application frequency from daily to every other day
Until recently, research showed that exogenous NMN had to become NR to enter human cells before it could go back to NMN and eventually become NAD+
Quality control considerations for the KLOW formulation include verification of individual peptide purity and identity, assessment of copper content and coordination in the GHK-Cu component, evaluation of peptide stability under storage conditions, and confirmation of biological activity for each component
Additional information Edited by A Stephanou Rights and permissions This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License
Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 32329684] PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context